| Allergan is a pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Co. operates and manages its business in three operating segments: U.S. Specialized Therapeutics, which provides eye care, neurosciences and urology therapeutic products; U.S. General Medicine, which focuses on newly developed pharmaceutical products; and International, which provides an array of aesthetics products outside of the U.S. Co.'s portfolio of products include Alloderm® for skin graft and Alphagan®/Combigan® as selective alpha2 agonist. The Allergan YTD return is shown above.
The YTD Return on the Allergan YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether Allergan YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the AGN YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.